Brain Scientific Valuation

BRSF Stock  USD 0.75  0.00  0.00%   
Brain Scientific is overvalued. Brain Scientific shows a prevailing Real Value of $0.63 per share. The current price of the firm is $0.75. Our model approximates the value of Brain Scientific from analyzing the firm fundamentals such as operating margin of (28.77) %, and Return On Equity of -45.97 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
0.75
Please note that Brain Scientific's price fluctuation is very steady at this time. Calculation of the real value of Brain Scientific is based on 3 months time horizon. Increasing Brain Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Brain pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Brain Scientific. Since Brain Scientific is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Brain Pink Sheet. However, Brain Scientific's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.75 Real  0.63 Hype  0.75 Naive  0.75
The real value of Brain Pink Sheet, also known as its intrinsic value, is the underlying worth of Brain Scientific Company, which is reflected in its stock price. It is based on Brain Scientific's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Brain Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.63
Real Value
0.83
Upside
Estimating the potential upside or downside of Brain Scientific helps investors to forecast how Brain pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Brain Scientific more accurately as focusing exclusively on Brain Scientific's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.750.750.75
Details
Hype
Prediction
LowEstimatedHigh
0.750.750.75
Details
Naive
Forecast
LowNext ValueHigh
0.750.750.75
Details

Brain Scientific Total Value Analysis

Brain Scientific is currently projected to have valuation of 12.28 M with market capitalization of 316.21 M, debt of 9.97 M, and cash on hands of 3.54 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Brain Scientific fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
12.28 M
316.21 M
9.97 M
3.54 M

Brain Scientific Investor Information

About 24.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.3. Brain Scientific had not issued any dividends in recent years. The entity had 1:85 split on the 3rd of February 2023. Based on the measurements of operating efficiency obtained from Brain Scientific's historical financial statements, Brain Scientific is not in a good financial situation at this time. It has a very high probability of going through financial hardship in October.

Brain Scientific Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Brain Scientific has an asset utilization ratio of 1.99 percent. This implies that the Company is making $0.0199 for each dollar of assets. An increasing asset utilization means that Brain Scientific is more efficient with each dollar of assets it utilizes for everyday operations.

Brain Scientific Ownership Allocation

Brain Scientific holds a total of 105.4 Million outstanding shares. Brain Scientific retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Brain Scientific Profitability Analysis

The company reported the previous year's revenue of 265.75 K. Net Loss for the year was (9.1 M) with profit before overhead, payroll, taxes, and interest of 83.23 K.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Brain Scientific's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Brain Scientific and how it compares across the competition.

About Brain Scientific Valuation

The pink sheet valuation mechanism determines Brain Scientific's current worth on a weekly basis. Our valuation model uses a comparative analysis of Brain Scientific. We calculate exposure to Brain Scientific's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Brain Scientific's related companies.
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.

8 Steps to conduct Brain Scientific's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Brain Scientific's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Brain Scientific's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Brain Scientific's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Brain Scientific's revenue streams: Identify Brain Scientific's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Brain Scientific's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Brain Scientific's growth potential: Evaluate Brain Scientific's management, business model, and growth potential.
  • Determine Brain Scientific's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Brain Scientific's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Brain Scientific Growth Indicators

Investing in growth stocks can be very risky. If the company such as Brain Scientific does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding50.2 M
Retained Earnings-22.3 M

Complementary Tools for Brain Pink Sheet analysis

When running Brain Scientific's price analysis, check to measure Brain Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brain Scientific is operating at the current time. Most of Brain Scientific's value examination focuses on studying past and present price action to predict the probability of Brain Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brain Scientific's price. Additionally, you may evaluate how the addition of Brain Scientific to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes